Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Cell Viability Assays Market In The Coming Years?

In recent years, there’s been a notable expansion in the cell viability assays market. Projected growth sees the market value rising from $1.56 billion in 2024 to $1.73 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. This significant growth during the historic period can be ascribed to several factors such as enhanced investment in cancer-related research, an upsurge in pharmaceutical R&D spending, and expansion in the biotechnology sector. Other contributing factors include advancements in cell culture techniques, increasing demand for stem cell research, the growing necessity for toxicity testing, and an increase in the application of real time cell analysis systems. Additionally, an increase in the quantity of CROs (contract research organizations) has also played a vital role.

Expectations are high for robust growth in the cell viability assays market size over the next few years, with projected growth reaching $2.52 billion in 2029, reflecting a compound annual growth rate (CAGR) of 9.9%. The surge expected during the forecast period can be credited to the rising demand for customized medicine, an uptick in government funds for cell-based research, a growing emphasis on precision medicine and stem cell research applications, increased accessibility to automated cell viability analyzers, and a heightened occurrence of infectious diseases. Other contributing factors include enhanced focus on bettering assay precision and responsiveness, elevated awareness of the advantages of cell viability assays, increased development of organ-on-a-chip technologies, and burgeoning demand for regenerative medicine. The forecast period is also set to witness major trends including advancements in high throughput screening methods, the incorporation of AI and machine learning algorithms, the advent of real-time monitoring systems, the adoption of automated liquid handling systems, the formulation of multiplex assays for simultaneous cell viability measurement, adoption of greener and more sustainable reagents, the creation of user-friendly assay kits, advancements in electrochemical assays, the introduction of scalable cell viability assays, and the production of assays that are compatible with primary cells and stem cells.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

What Drivers Are Accelerating Expansion Of The Cell Viability Assays Market?

The growth of the cell viability assay market is anticipated to be driven by the surging cell-based therapeutics. These treatments involve the use of live cells to mend or substitute damaged tissue, treat diseases or reinstate standard functionality. This progress in cell-based therapeutics can be attributed to advancements in biotechnology, an upsurge in investment in regenerative medicine, escalating acceptance and implementation of cell therapies, along with development in cell engineering and manufacturing technologies. The functionality, safety, and health of therapeutic cells are assured by cell viability assays, hence enhancing treatment efficacy and quality control. As reported by the American Society of Gene & Cell Therapy, a not-for-profit medical and scientific organization based in the U.S., there were 38 trials in Q1 2023 for non-genetically modified cell therapies, an increase from the previous quarter, Q4 2022 by 7. Therefore, the cell viability assay market is propelled by the rise in cell-based therapeutics.

How Is The Global Cell Viability Assays Market Broken Down By Segment?

The cell viability assaysmarket covered in this report is segmented –

1) By Product: Consumables; Instruments

2) By Application: Basic Research; Stem Cell Research; Drug Discovery And Development; Clinical And Diagnostic Applications; Other Applications

3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospital And Diagnostic Laboratories; Other End-Users

Subsegments:

1) By Consumables: Reagents; Kits; Assay Plates (96-Well plates); Microplates

2) By Instruments: Spectrophotometers; Fluorometers; Microplate Readers; Flow Cytometers; Imaging Systems

Which Market Trends Are Expected To Define The Future Of The Cell Viability Assays Market?

Leading enterprises within the cell viability assays market are focusing on creating advanced cell screening technologies to enhance precision and accelerate drug discovery processes. Such technologies significantly aid cell viability assays by allowing rapid, meticulous, and high-capacity analysis of cell health and reactions, thereby fine-tuning experimental conditions and bolstering the creation of therapy strategies. Take an example from May 2024 when Arralyze, a German tech firm, launched CellShepherd, a futuristic platform for single-cell examination. The platform relies on patented nanowell glass arrays to downsize cell-based assays for real-time tracking. This self-sufficient system renders accurate cell dispensing, co-culturing in sterile scenarios, and brightfield and fluorescent channel imaging. The AI-assisted analysis ensures precise cell counting and monitoring. Additionally, by being easy to use, this platform meets the growing demand for exact single-cell studies in the areas of biomedical and life science.

Which Firms Are Making The Biggest Impact In The Cell Viability Assays Market?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Cell Viability Assays Market?

North America was the largest region in the cell viability assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

Browse Through More Reports Similar to the Global Cell Viability Assays Market 2025, By The Business Research Company

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Stem Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cellulars Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model